In biopharmaceutical manufacturing, downtime is one of the most significant barriers to productivity and profitability. Unplanned stoppages, lengthy cleaning cycles, and inefficient changeovers can delay production timelines and impact supply chains—especially in facilities producing critical sterile-formulations. To address these challenges, manufacturers are increasingly...